Additionally, the patients with HT and NAFLD had higher WC, total cholesterol, triglycerides, fasting insulin and HOMA-IR levels than the patients with HT without NAFLD. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.